Tafalgie Therapeutics: an alternative painkiller to opioids

Tafalgie Therapeutics is developing a new generation of pain-relieving peptides devoid of the disabling side effects of opioids.

This start-up is one of Challenges’ “100 start-ups to invest in in 2024”.


Visit our contact page